Home » Serum Institute to invest £240 million...

Serum Institute to invest £240 million to expand its vaccine business in UK

Sumit Arora Published On May 7th, 2021 Leave a comment

Serum Institute of India (SII) is expanding its vaccine business in the United Kingdom with an investment of £240 million. The serum has already started phase one trials in the UK of a one-dose nasal vaccine for coronavirus, in partnership with Codagenix INC. This was a part of the £533 million of new Indian investment in the UK in growing sectors such as health and technology.

Buy Prime Test Series for all Banking, SSC, Insurance & other exams

Serum’s investment will support clinical trials, research & development and possibly manufacturing of vaccines. This will help the UK and the world to defeat the coronavirus pandemic and other deadly diseases.

Important takeaways for all competitive exams:

The SII was founded by Cyrus Poonawalla (Adar Poonawalla’s father) in 1966.
Adar Poonawalla joined the Serum Institute of India in 2001 and became the CEO of the company in 2011.

Find More National News Here

About the Author

Sumit Arora

Author

As a team lead and current affairs writer at Adda247, I am responsible for researching and producing engaging, informative content designed to assist candidates in preparing for national and state-level competitive government exams. I specialize in crafting insightful articles that keep aspirants updated on the latest trends and developments in current affairs. With a strong emphasis on educational excellence, my goal is to equip readers with the knowledge and confidence needed to excel in their exams. Through well-researched and thoughtfully written content, I strive to guide and support candidates on their journey to success.